Teladoc Health, Inc. TDOC reported second-quarter 2026 revenue of $606.9 million, down 3.95% from a year ago and below the $627.7 million estimate. Gross profit came in at $416.1 million, while operating loss widened to $37.1 million.
The company posted a net loss attributable to common shareholders of $38.9 million, or $(0.21) per diluted share. That compared with an EPS estimate of $(0.25), and marked an improvement in per-share results from the prior year.
Cash flow from operations totaled $64.7 million, and cash and cash equivalents ended the period at $774.3 million. Total liabilities were $1.4 billion.
- Revenue: $606.9 million
- Gross profit: $416.1 million
- Operating loss: $37.1 million
- Net loss: $38.9 million
- Operating cash flow: $64.7 million
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Teladoc Health, Inc. Insider Trading Activity
Teladoc Health, Inc. insiders have traded $TDOC stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $TDOC stock by insiders over the last 6 months:
- CHARLES III DIVITA (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 4 sales selling 115,082 shares for an estimated $680,224.
- KELLY BLISS (President, U.S. Group Health) has made 0 purchases and 5 sales selling 41,826 shares for an estimated $262,420.
- ADAM C VANDERVOORT (CHIEF LEGAL OFFICER, SECRETARY) has made 0 purchases and 2 sales selling 34,989 shares for an estimated $198,882.
- FERNANDO M. RODRIGUES (President of BetterHelp) has made 0 purchases and 2 sales selling 15,249 shares for an estimated $114,131.
- CARLOS NUENO (President, International) sold 6,196 shares for an estimated $47,256
- JOSEPH RONALD CATAPANO (Chief Accounting Officer) has made 0 purchases and 4 sales selling 2,945 shares for an estimated $18,381.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Teladoc Health, Inc. Hedge Fund Activity
We have seen 151 institutional investors add shares of Teladoc Health, Inc. stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VOSS CAPITAL, LP added 4,200,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,890,000
- NUVEEN, LLC removed 2,135,660 shares (-80.3%) from their portfolio in Q1 2026, for an estimated $11,639,347
- MONACO ASSET MANAGEMENT SAM added 2,073,209 shares (+105.9%) to their portfolio in Q1 2026, for an estimated $11,298,989
- POINT72 ASSET MANAGEMENT, L.P. added 2,060,173 shares (+36.4%) to their portfolio in Q1 2026, for an estimated $11,227,942
- ALLIANZ ASSET MANAGEMENT GMBH added 1,676,172 shares (+53.8%) to their portfolio in Q1 2026, for an estimated $9,135,137
- MILLENNIUM MANAGEMENT LLC removed 1,510,686 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,233,238
- FREESTONE GROVE PARTNERS LP added 1,509,954 shares (+inf%) to their portfolio in Q1 2026, for an estimated $8,229,249
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Teladoc Health, Inc. Price Targets
Multiple analysts have issued price targets for $TDOC recently. We have seen 14 analysts offer price targets for $TDOC in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Allen Lutz from B of A Securities set a target price of $10.5 on 07/07/2026
- Daniel Grosslight from Citigroup set a target price of $7.0 on 05/05/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $6.0 on 04/08/2026
- Glen Santangelo from Barclays set a target price of $7.0 on 03/26/2026
- Lisa Gill from JP Morgan set a target price of $7.0 on 03/13/2026
- George Hill from Deutsche Bank set a target price of $11.0 on 03/10/2026
- Michael Wiederhorn from Oppenheimer set a target price of $7.0 on 03/03/2026
